Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
-
Ann. Allergy Asthma Immunol. · Mar 2005
Natural history of large local and generalized cutaneous reactions to imported fire ant stings in children.
There are no published data on the natural history of large local and generalized cutaneous reactions to imported fire ant (IFA) stings in children. ⋯ These limited data on IFA stings suggest a benign outcome in children 16 years and younger with large local or generalized cutaneous reactions. Larger and more extensive studies need to be conducted to further define the natural history of cutaneous reactions to IFA stings in children.
-
Ann. Allergy Asthma Immunol. · Dec 2004
Comparative StudyEffect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
Inhaled corticosteroids are the most effective class of anti-inflammatory agents and are recommended for patients with persistent asthma. ⋯ Patients with symptomatic asthma previously treated with short-acting beta2-agonists only who require maintenance therapy are likely to have greater clinical benefits, lower risk of an asthma exacerbation, and reduced exacerbation-related costs when initiating therapy with fluticasone propionate-salmeterol vs fluticasone propionate or montelukast.
-
Ann. Allergy Asthma Immunol. · Nov 2004
Measuring asthma disparities in Hispanics: adherence to the national guidelines for asthma treatment in emergency departments in Puerto Rico.
Puerto Rico has the highest prevalence of asthma in the United States. Currently, there are no data on actual care given to asthmatic patients. ⋯ Of the variables tested, only one had acceptable levels of compliance, as evidenced in the patient's records, indicating that there are alarming differences in ED evaluation and treatment compared with the 1997 National Asthma Education Prevention Program guidelines.
-
Ann. Allergy Asthma Immunol. · Oct 2004
Randomized Controlled Trial Multicenter Study Comparative Study Clinical TrialFluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
Optimal therapy for many patients with persistent asthma requires control of both main components of this disease: inflammation and bronchoconstriction. ⋯ In patients symptomatic while taking short-acting beta2-agonists alone, initial maintenance treatment of the 2 main components of asthma, inflammation and smooth muscle dysfunction, with fluticasone propionate and salmeterol, 100 and 50 microg, administered via the Diskus results in greater improvements in overall asthma control compared with treatment of either component alone.